loading
전일 마감가:
$6.48
열려 있는:
$6.5
하루 거래량:
902.88K
Relative Volume:
0.41
시가총액:
$2.34B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-13.15
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
-1.71%
1개월 성능:
+2.10%
6개월 성능:
-15.19%
1년 성능:
-14.50%
1일 변동 폭
Value
$6.30
$6.5293
1주일 범위
Value
$6.23
$6.5293
52주 변동 폭
Value
$3.96
$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
명칭
Bausch Health Companies Inc
Name
전화
514-744-6792
Name
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
직원
20,700
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
BHC's Discussions on Twitter

BHC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
6.31 2.37B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
148.60 68.99B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.43 46.36B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.60 44.74B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.06 18.81B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
292.01 13.33B 2.99B 1.21B 1.13B 25.06

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-02 다운그레이드 Piper Sandler Neutral → Underweight
2024-07-10 개시 Raymond James Mkt Perform
2023-09-20 업그레이드 Jefferies Hold → Buy
2023-06-16 다운그레이드 TD Cowen Outperform → Market Perform
2022-07-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-07-29 다운그레이드 Truist Buy → Hold
2022-07-28 다운그레이드 JP Morgan Overweight → Neutral
2022-06-13 재개 JP Morgan Overweight
2021-03-24 다운그레이드 BofA Securities Neutral → Underperform
2021-02-17 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2021-01-22 다운그레이드 Piper Sandler Overweight → Neutral
2020-09-17 업그레이드 BofA Securities Underperform → Neutral
2020-08-24 재확인 H.C. Wainwright Buy
2020-06-17 재확인 H.C. Wainwright Buy
2020-04-24 개시 Citigroup Buy
2020-04-02 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-01-29 다운그레이드 Wolfe Research Outperform → Peer Perform
2020-01-22 업그레이드 Wells Fargo Underweight → Equal Weight
2019-12-12 업그레이드 JP Morgan Neutral → Overweight
2019-12-02 개시 Goldman Neutral
2019-10-25 개시 Cowen Outperform
2019-09-12 개시 Guggenheim Buy
2019-08-15 업그레이드 TD Securities Hold → Buy
2019-07-19 개시 Wolfe Research Outperform
2019-06-11 재개 Barclays Overweight
2019-05-13 업그레이드 JP Morgan Underweight → Neutral
2019-03-20 개시 SunTrust Buy
2019-01-02 업그레이드 Piper Jaffray Neutral → Overweight
2018-11-05 업그레이드 Morgan Stanley Equal-Weight → Overweight
2018-09-13 업그레이드 Piper Jaffray Underweight → Neutral
모두보기

Bausch Health Companies Inc 주식(BHC)의 최신 뉴스

pulisher
08:54 AM

What analysts say about Bausch Health Companies Inc. stockFree Investment Timing Strategies - Jammu Links News

08:54 AM
pulisher
01:44 AM

What drives Bausch Health Companies Inc. stock priceRemarkable growth - Jammu Links News

01:44 AM
pulisher
Jul 18, 2025

Is Bausch Health Companies Inc. a good long term investmentPhenomenal returns - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - The Motley Fool Canada

Jul 17, 2025
pulisher
Jul 15, 2025

Bausch Health Faces Patent Drama And Policy Questions This Quarter - Finimize

Jul 15, 2025
pulisher
Jul 15, 2025

Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

In the Wake of Bausch Health Companies Inc.'s (NYSE:BHC) Latest US$196m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Amblyopia Market Growth Expected to See Next Level with Novartis - openPR.com

Jul 15, 2025
pulisher
Jul 12, 2025

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance

Jul 12, 2025
pulisher
Jul 11, 2025

Icahn Enterprises shares rise 5.72% intraday after Bausch Health appoints new Chief Accounting Officer. - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Bausch Health's Strategic Leadership Shift: Steven Lee's Expertise Could Propel Valuation Growth Amid Transformation - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

First-Ever Triple-Combination Acne Treatment CABTREO Expands Access Across Canadian Health Programs - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Names Steven Lee Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Appoints New Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Strengthens Finance Team: M&A Expert Steven Lee Takes Chief Accounting Officer Role - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Groundbreaking Triple-Combination Acne Treatment Expands Access Across Canadian Healthcare System - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs - Yahoo Finance

Jul 09, 2025
pulisher
Jul 07, 2025

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - standard-journal.com

Jul 07, 2025
pulisher
Jul 07, 2025

First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan

Jul 07, 2025
pulisher
Jul 03, 2025

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 03, 2025

Bausch Health Companies Reaches Analyst Target Price - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

Stocks In Play: Bausch Health Companies - Barchart.com

Jul 02, 2025
pulisher
Jul 02, 2025

Bausch Health to Announce Second Quarter 2025 Results on July 30 - Corsicana Daily Sun

Jul 02, 2025
pulisher
Jul 01, 2025

Bausch + Lomb's Dry Eye Campaign: A Strategic Opportunity in Growing Eye Health Markets - AInvest

Jul 01, 2025
pulisher
Jun 29, 2025

BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 29, 2025
pulisher
Jun 26, 2025

Bausch + Lomb Brief: Closes Upsized 675 Million Euro Senior Secured Notes Offering and Partial Credit Agreement Refinancing - MarketScreener

Jun 26, 2025
pulisher
Jun 20, 2025

Fed. Circ. Revives MSN Challenge To Bausch IBS Drug Patent - Law360

Jun 20, 2025
pulisher
Jun 18, 2025

Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Bausch Health ticks higher following large director stock purchase - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 17, 2025
pulisher
Jun 17, 2025

Bausch Health Companies: Insider Confidence Fuels Undervalued Stock's Turnaround Potential - AInvest

Jun 17, 2025
pulisher
Jun 16, 2025

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Director buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 15, 2025

Bausch Health Companies Inc. (TSE:BHC) Director John Paulson Acquires 754,134 Shares - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

LOOK: These 10 Stocks Just Stole The Show - Insider Monkey

Jun 14, 2025
pulisher
Jun 13, 2025

Bausch Health (BHC) Rises After Director's $15M Share Purchase - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Bausch Health Companies Stock Price, Quotes and Forecasts | NYSE:BHC - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

Hedge Fund and Insider Trading News: Philippe Laffont, Warren Buffett, Bill Ackman, Farallon Capital, Bausch Health Companies Inc (BHC), MicroStrategy Inc (MSTR), and More - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Rising Demand in Traveler's Diarrhea MarketTop Developments, - openPR.com

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Benzodiazepine Drugs Market Trends, Growth Forecast, and Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 06, 2025

Huntington's Disease Market Grows with Increased Genetic - openPR.com

Jun 06, 2025
pulisher
Jun 04, 2025

Reconstructive Surgery Market Trends, Size & Growth Forecast - openPR.com

Jun 04, 2025

Bausch Health Companies Inc (BHC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.18
price down icon 4.65%
$14.78
price down icon 1.20%
$8.88
price down icon 4.21%
drug_manufacturers_specialty_generic RDY
$14.48
price down icon 1.43%
$132.02
price down icon 1.56%
$292.01
price down icon 1.79%
자본화:     |  볼륨(24시간):